🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 25% of ingredients have research evidence
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

3 Tablet(s) Serving Size
90 Servings
Mineral Product Type
25% Evidence Coverage

Supplement Facts — Evidence Check

Total Carbohydrates
1 Gram(s) (1% DV)
Calcium
620 mg (48% DV)
360 mg (29% DV)
✅ Within RDA (0.5× RDA of 700 mg) 📚 12 studies (Tier A: 0, B: 3)
RDA 700mg This product: 360mg UL 4000mg
Microcrystalline Hydroxyapatite Concentrate
1.5 Gram(s)

Other Ingredients

Microcrystalline Cellulose Stearic Acid Cellulose Croscarmellose Sodium Silica Hypromellose Medium Chain Triglyceride Hydroxypropyl Cellulose

Label Claims — Verification

Nutrient
All Other
Structure/Function
All Other (99% of products) Structure/Function (85% of products) Nutrient (54% of products) Approved Health (3% of products)

Target Groups

Adult (18 - 50 Years) Gluten Free

Product Information

📋 Directions for Use

Directions: Take three tablets once daily or as directed by your healthcare practitioner.

⚠️ Warnings & Precautions

Caution: If pregnant, nursing, or taking medication, consult your healthcare practitioner before use.

Keep out of reach of children.

Tamper evident: Do not use if safety seal is missing or broken.

Practitioner exclusive

🧪 Formulation Notes

Bone Builder provides bone health support with microcrystalline hydroxyapatite concentrate (MCHC), a highly absorbable crystalline compound comprised of naturally-occurring components of bone which is backed by more than 30 years of research. MCHC contains naturally occurring calcium, phosphorus, and trace amounts of other minerals, bone growth factors, collagen and other vital bone proteins. This well-rounded formula is designed to support bone mineral density. Ideal for those who prefer tablets.

This product is non GMO and gluten free.

Enhanced bone support

Additional Information

Storage: Keep tightly closed in a cool, dry place.

Non GMO Project Verified Nongmoproject.org Certified Gluten Free GFCO.org

Product Details

UPC / SKU 7 55571 01311 8
DSLD Entry Date 2023-08-23
Product Type Mineral
Form Tablet or Pill
Brand Metagenics
DSLD ID 295634
Data Updated 2026-04-11

Research Evidence

849 Research Sources
56 Avg Quality Score
450 Meta Analysis
152 Rct
137 Systematic Review
73 Clinical Trial
11 Regulatory Source
7 Other
7 Guideline
3 Openfda Safety
2 Cochrane Review
2 Observational
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2024
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2015
A Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
Meta Analysis The Cochrane database of systematic reviews 2018
A Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Meta Analysis The Cochrane database of systematic reviews 2025
A Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
Systematic Review The Cochrane database of systematic reviews 2008
A Calcium and vitamin D for increasing bone mineral density in premenopausal women
Systematic Review The Cochrane database of systematic reviews 2023
A Dietary sodium, sodium-to-potassium ratio, and risk of stroke: A systematic review and nonlinear dose-response meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2019
A The association between circulating magnesium and clinically relevant outcomes in patients with chronic kidney disease: A systematic review and meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2021
A Calcium channel blockers versus other classes of drugs for hypertension
Systematic Review The Cochrane database of systematic reviews 2021
View all evidence for Electrolytes →

Compare Similar Products

View all Electrolytes products →